Philippe Laffont’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Philippe Laffont’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-55,979	Closed	-$1.39M	–	100
2023 Q2	$1.39M	Sell	55,979 -8,937	-14%	-$262K	0.01%	91
2023 Q1	$2.36M	Sell	64,916 -5,738	-8%	-$352K	0.02%	70
2022 Q4	$4.26M	Hold	70,654	–	–	0.05%	64
2022 Q3	$5.3M	Hold	70,654	–	–	0.06%	74
2022 Q2	$8.1M	Hold	70,654	–	–	0.1%	68
2022 Q1	$13.4M	Hold	70,654	–	–	0.1%	48
2021 Q4	$24.5M	Hold	70,654	–	–	0.11%	57
2021 Q3	$23M	Hold	70,654	–	–	0.09%	60
2021 Q2	$58.2M	Buy	+70,654	New	+$54.8M	0.23%	49

Other funds holding OMIC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Philippe Laffont's OMIC Position: Q3 2023 in Review

Philippe Laffont sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2023, closing a stake of 55,979 shares — an estimated $1.39M sold.

Philippe Laffont first reported a position in OMIC in Q2 2021 and held it in 9 quarters. The position peaked at $58.2M in Q2 2021. 48 funds tracked by Wall St. Rank hold OMIC as of Q3 2023.

Philippe Laffont reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Philippe Laffont sold 55,979 Singular Genomics Systems, Inc. Common Stock shares in Q3 2023, an estimated $1.39M.
Philippe Laffont first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
Philippe Laffont's Singular Genomics Systems, Inc. Common Stock position peaked at $58.2M in Q2 2021.
48 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2023.

Based on Coatue Management's 13F filing for Q3 2023, filed 14 Nov 2023.